이상반응 보고

VAERS ID	2247513
성별	여성
나이	58세
주 코드	FR
제약회사	MODERNA
로트 번호
예방접종 횟수	3
접종일	2022-03-31
발병일	2022-04-01
상태	사망

증상

• 심장 불편(Cardiac discomfort)

이환 중 질병

지병

기타 의료

이전 예방접종

알레르기

임상 검사

증상 상세

The family member said that the patient began to feel cardiac discomfort after the third dose of Moderna on March 31.
; This regulatory authority case was reported by an other health care professional and describes the occurrence of CARDIAC DISCOMFORT (The family member said that the patient began to feel cardiac discomfort after the third dose of Moderna on March 31.
) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.
No Medical History information was reported.
On 31-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.
On 01-Apr-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CARDIAC DISCOMFORT (The family member said that the patient began to feel cardiac discomfort after the third dose of Moderna on March 31.
) (seriousness criterion death).
It is unknown if an autopsy was performed.
For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
No concomitant medications were reported.
On 01-Apr-2022, the family member said that the patient began to feel cardiac discomfort after the third dose of Moderna on 31-Mar.
The family member just wanted to find the patient and found that the patient had been lying at home with the duration unknown.
Upon follow-up on 06-Apr-2022, the patient was called at 10:45, but no one answered the phone call.
No treatment medication was provided.
Company comment: This is a regulatory authority case concerning a 58-year-old, female patient with no reported medical history, who experienced the unexpected serious (death according to regulatory authority) event of cardiac discomfort.
The event occurred approximately 1 day after the third dose of mRNA-1273 vaccine administration.
The event was described as, patient began to feel cardiac discomfort after the third dose of mRNA-1273 vaccine administration.
Approximately 6 days after the third dose of mRNA-1273 vaccine administration the patient was called but no one answered the phone.
On unknown date, the family member just wanted to find the patient and found that the patient had been lying at home with the duration unknown.
It is unknown if autopsy was performed and no reported cause of death.
The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
; Sender's Comments: This is a regulatory authority case concerning a 58-year-old, female patient with no reported medical history, who experienced the unexpected serious (death according to regulatory authority) event of cardiac discomfort.
The event occurred approximately 1 day after the third dose of mRNA-1273 vaccine administration.
The event was described as, patient began to feel cardiac discomfort after the third dose of mRNA-1273 vaccine administration.
Approximately 6 days after the third dose of mRNA-1273 vaccine administration the patient was called but no one answered the phone.
On unknown date, the family member just wanted to find the patient and found that the patient had been lying at home with the duration unknown.
It is unknown if autopsy was performed and no reported cause of death.
The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.